The Company achieved a total revenue of $13.6 million. Gross Profit Margins continue to demonstrate a solid performance with 30% growth year-over-year. SG&A achieves a significant reduction, reflecting the Company's notable 32% decrease year-over-year. EBITDA improves by 70% for the quarter and 65% year-over-year, reflecting progress toward profitability. Management will host a conference call on November 29, 2024, at 10... Read More

TORONTO, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, announced today that the Company's third quarter 2024 financial results will be released after market close on Thursday, November 28, 2024. The Company will host a conference call to discuss these results and provide an... Read More

TORONTO, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, announced earlier it was in breach of certain financial covenants and other obligations under each of its Senior Credit Agreement and Subordinated Credit agreements with an affiliate of the LiUNA Pension Fund of Central... Read More

TORONTO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE: 4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, confirmed today it has signed an amendment (the " Amendment ") to its senior secured amended and restated credit facility entered into on January 31, 2023 (the " Credit Facility ") with an affiliate of the LiUNA... Read More

TORONTO, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, announced earlier it was in breach of certain financial covenants and other obligations under each of its Senior Credit Agreement and Subordinated Credit agreements with an affiliate of the LiUNA Pension Fund of Central... Read More

Total revenue of $12.2 million demonstrates the Company's solid momentum year over year and ongoing growth in the rapidly expanding bulk sales market. Entourage made a strong impact with new product launches across Alberta, Ontario, and British Columbia, including Color Cannabis' expanded flower offerings. Dime Bag continued its strong performance in Ontario, achieving a sequential increase in sales and hitting a... Read More

TORONTO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, announced today that the Company's second quarter 2024 financial results will be released after market close on Monday, August 26, 2024. The Company will host a conference call to discuss the results and provide an... Read More

TORONTO, June 12, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, is pleased to announce that shareholders overwhelmingly approved all proposed resolutions at its annual general meeting of shareholders (“AGM”) held virtually on June 12, 2024. All director nominees, as listed in the... Read More

Total revenue of $16.4 million represents a 9% increase year-over-year and a 23% sequential increase from Q4 2023. Gross profit before fair value changes improved by 92% year-over-year, leading to a record gross margin of 45%. This achievement reflects the successful execution of last year’s transformation plans. EBITDA improved by $4.4 million, marking the Company's first positive quarter and resulting in a 114%... Read More

TORONTO, May 14, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. ( TSX-V:ENTG ) ( OTCQX: ETRGF ) ( FSE:4WE ) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products announced today it will file its first quarter 2024 financial statements and management’s discussion and analysis after market close on Monday, May 27, 2024. Entourage will host a conference call the following... Read More

Entourage Unveils Exciting New Product Offerings Diversifying the Company’s Signature Brands Dime Bag ® Widens Reach: Popular Offerings Now Across Alberta TORONTO, May 08, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), an established Canadian producer and distributor of award-winning cannabis products, today unveiled the expansion of its product... Read More

Gross profit before fair value changes reached $2.4 million, reflecting a 126% year-over-year increase. Company demonstrates financial gains with a 23% reduction in the cost of goods sold. SG&A declined 14% compared to the previous year. Color Cannabis secures a #6 spot in the national pre-roll market. TORONTO, April 30, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE: 4WE) ("Entourage" or... Read More

TORONTO, April 24, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, announced today that it will file its financial statements and management's discussion and analysis for the fourth quarter and fiscal year ended December 31, 2023, after market close on April 29, 2024. The Company will... Read More

Chief Legal Officer and Corporate Secretary to step down effective December 18, 2023 TORONTO, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. ( TSX-V: ENTG ) ( OTCQX: ETRGF ) ( FSE:4WE ) (" Entourage " or the " Company "), a Canadian producer and distributor of award-winning cannabis products, today announced that Vincent Doré, Entourage's Chief Legal Officer and Corporate Secretary, will step down to pursue other... Read More

Entourage sees the benefits of transitioning from cultivation and reports over $10 million to date in annualized cost savings. Gross Profit Before Fair Value Changes has surged to $2.4 million, indicating a substantial margin of 27% and a 149% year-over-year increase. Management is to host a conference call on November 28, 2023, at 10 a.m. Eastern Time. TORONTO, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (... Read More

TORONTO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. ( TSX-V:ENTG ) ( OTCQX:ETRGF ) ( FSE:4WE ) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products announced today it will file its third quarter 2023 financial statements and management’s discussion and analysis after-market on Monday, November 27, 2023. Entourage will host a conference call the following day... Read More

Supply Agreement previously executed with HEXO Corp. is assigned to Aphria Inc., Tilray Brands, Inc.’s operating subsidiary for bulk cannabis biomass Amended Supply Agreement offers consistent premium cannabis to meet demand for Entourage products TORONTO, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of... Read More

The Company achieved a total revenue of $13.3 million, driven by an 8% increase in adult-use revenue and a significant 45% increase in pre-roll revenue year-over-year Gross Profit Before Fair Value Changes has surged to $2.15 million, indicating a substantial margin of 21% and a considerable year-over-year increase of 354% Adjusted EBITDA showed a 28% improvement as the Company realizes benefits from strategic transformation... Read More

Entourage addresses market demand for affordable premium cannabis with new brand, Dime Bag® The Company announces Syndicate, a collective of exclusive cultivars from micro-cultivators TORONTO, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE: 4WE) ("Entourage" or the "Company"), a leading Canadian producer and distributor of acclaimed cannabis products, unveils a wave of nostalgic... Read More

TORONTO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX: ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products announced today it will file its second quarter 2023 financial statements and management’s discussion and analysis after market on Tuesday, August 29, 2023. Entourage will host a conference call the following day on... Read More

Company successfully executes international sale and fulfilment of 100kg order of Bulk Medical Cannabis with Lyphe Australia Company also issues Deferred Share Units to Board of Directors as Quarterly Director’s Remuneration TORONTO, July 04, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. ( TSX-V: ENTG ) ( OTCQX: ETRGF ) ( FSE: 4WE ) (" Entourage " or the " Company "), a Canadian producer and distributor of award-winning... Read More

Senior secured credit facility is repaid in part from proceeds of facility sale and the balance assumed by LPF Sale of Strathroy facility concludes site optimization strategy initiated in late 2022; with net proceeds of sale primarily used to satisfy debt TORONTO, June 19, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. ( TSX-V: ENTG ) ( OTCQX: ETRGF ) ( FSE: 4WE ) (" Entourage " or the " Company "), a Canadian producer and... Read More

TORONTO, June 14, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. ( TSX-V:ENTG ) ( OTCQX:ETRGF ) ( FSE:4WE ) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products, is pleased to announce that shareholders overwhelmingly approved all proposed resolutions at its annual general meeting of shareholders (“AGM”) held virtually in Toronto, Ontario on June 14, 2023. All director... Read More

Total revenue of $15.1 million in Q1 2023 represents a 24% sequential increase over Q4 2022. Net Revenue in medical accounted for $6.0 million, a 61% sequential increase over Q4 2022. Color Cannabis captured a 5.3% national market share in the pre-roll segment. 1 Management will host a conference call on May 30, 2023, at 10 a.m. Eastern Time. TORONTO, May 30, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. ( TSX-V: ENTG ) (... Read More

Company financials to be filed after market on May 29, 2023, and operational outlook to be provided during call, including milestones achieved. Company announces issuance of 1,423,057 common shares from treasury in satisfaction of previously announced shares for debt transaction. TORONTO, May 15, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company") , a Canadian... Read More

Record net medical revenue of $17.4 million for 2022, representing 16% growth Entourage secured a 5% share of total sales, ranking them in the fourth spot of national pre-roll sales in 2022 Upsized credit facility with LiUNA Pension Fund Central and Eastern Canada (“LPF”) improves liquidity position TORONTO, May 01, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) ("Entourage" or the... Read More

TORONTO, April 21, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, announced today that it will file its financial statements and management’s discussion and analysis for the fourth quarter and fiscal year ended December 31, 2022, by Monday, May 1, 2023. The Company will defer its... Read More

TORONTO, April 14, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, announced today that it will file its financial statements and management’s discussion and analysis for the fourth quarter and fiscal year ended December 31, 2022, after market close on Thursday, April 27, 2023. The... Read More

TORONTO, April 03, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, announced today that, in accordance with the provisions of its omnibus equity incentive compensation plan (the “Omnibus Plan”), the Company has authorized the issuance of an aggregate of 1,600,000 deferred share units... Read More

Starseed continues to solidify its position as an industry leader leveraging its innovative medical cannabis products to include unique CBD chewing gum Plan administrator Union Benefits adds an additional union group and provides access to medical cannabis as an insured benefit TORONTO, March 27, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian... Read More

TORONTO, March 02, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products and brands, is pleased to announce the expansion of its brand portfolio with new offerings. The Company's Color Cannabis and Saturday Cannabis adult-use products include distinct cultivars, large-format flower and... Read More

TORONTO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products and brands, is pleased to announce it has successfully closed the second $15 million tranche of its upsized credit facility (the “ Credit Facility ”) with an affiliate of the LiUNA Pension Fund of Central and Eastern... Read More

Consumer-facing cannabis awards recognize the brands' 'Just Add Color' marketing campaign as the best in 2022 Company’s Chief People Officer resigning effective February 1, 2023 TORONTO, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products and brands, is pleased to announce Color... Read More

TORONTO, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products confirmed today it has signed an amendment (the “Amendment”) to its senior secured amended and restated credit facility entered into on October 28, 2022 (the “Credit Facility”). The Amendment provides a waiver to the... Read More

Company signs three-year supply agreement with HEXO Corp. to buy bulk cannabis for its expanding retail distribution and increased medical offerings Entourage to transition away from cultivation as it phases out growing facilities, generating annualized cost savings of over $10 million and anticipated margin accretion Steadily improves capital structure with upsized credit facility for increased liquidity Management to host... Read More

TORONTO, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products announced today it will file its third quarter 2022 financial statements and management’s discussion and analysis after-market on Monday November 14, 2022. Entourage will host a conference call the following day on... Read More

Entourage Health Corp. ( ( TSX-V:ENTG ) (OTCQX:ETRGF) (FSE:4WE) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products and brands, is pleased to announce it has amended and upsized its existing credit facility (the “ Credit Facility ”) with an affiliate of the LiUNA Pension Fund of Central and Eastern Canada (“ LPF ”), providing an additional $30 million in funding... Read More

Debuts: ‘Color Calendar’, a unique take on an adult-use Advent calendar featuring 24 pre-rolls; ‘Saturday Cranberry Sauce’ vape; ‘Color Live Resin Soft Chews’ and 'Color Infused Pre-Rolls' The Boston Beer Company’s cannabis-infused ‘TeaPot’ beverages arrive in Ontario, early Nov. Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (" Entourage " or the " Company "), a Canadian producer and distributor of... Read More

Syndicate marketplace showcases a variety of specially curated products and formats made in-house and/or sourced from micro-cultivators looking for a medical distribution outlet As a supplemental market to insured benefits channel Starseed Medicinal, Syndicate will offer clients sans insurance access a variety of brand favourites including Color & Saturday Cannabis Entourage Health Corp. ( TSX-V:ENTG ) ( OTCQX:ETRGF ) (... Read More

Entourage Health Corp. ( TSX-V:ENTG ) ( OTCQX:ETRGF ) ( FSE:4WE ) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products is pleased to announce the appointment of James Afara as the Company’s Chief Operating Officer (COO). A results-driven leader with an exceptional track record, James brings over 15 years of operations and supply chain experience to Entourage, serving most... Read More

Entourage Health Corp. ( TSX-V:ENTG ) ( OTCQX:ETRGF ) ( FSE:4WE ) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products, is pleased to announce its medical subsidiary Starseed Medicinal (“ Starseed ”) has added four new union groups to its full-service, proprietary medical cannabis program, in partnership with leading benefits provider Union Benefits – the administrator of... Read More

Entourage Health Corp. ( TSX-V:ENTG ) ( OTCQX:ETRGF ) ( FSE:4WE ) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products, announced today its financial results for the three and six months ended June 30, 2022. The Company reported second quarter 2022 total revenue of $13.2 million and net revenue of $9.7 million, a slight total revenue decrease of 5.0% and net revenue... Read More

Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products announced today it will file its second quarter 2022 financial statements and management’s discussion and analysis after-market on Monday, August 29, 2022. Entourage will host a conference call the following day on Tuesday, August 30, 2022 at 10 a.m. Eastern Time... Read More

Irwin-branded cannabis products will be first available to Starseed Medicinal patients in Q4 2022 Strategic nutraceuticals partnership follows recent release of recommendations for easing access to over-the-counter CBD-products in pharmacies Entourage Health Corp. ( TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company” ), a Canadian producer and distributor of award-winning cannabis products is pleased to... Read More

Entourage Health Corp. ( TSX-V:ENTG ) ( OTCQX:ETRGF ) ( FSE:4WE ) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products, confirmed today it has satisfied certain conditions in connection with the recent amendments to its existing senior secured credit facility entered into on March 29, 2019 (the “ Senior Credit Facility ”) between the Company and Bank of Montreal, and its... Read More

Starseed signs with HelloMD’s telehealth network to support high volume of patient consultations Debuts customized patient treatment plans which could support pain management and opioid-displacement Entourage Health Corp. ( TSX-V:ENTG ) ( OTCQX:ETRGF ) ( FSE:4WE ) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products is pleased to announce the expansion of its Starseed... Read More

Entourage Health Corp. ( TSX-V:ENTG ) ( OTCQX:ETRGF ) ( FSE:4WE ) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products, is pleased to announce it has amended its existing senior secured credit facility entered into on March 29, 2019 (the “ Senior Credit Facility ”) between the Company and Bank of Montreal, and its existing second secured credit facility with an affiliate... Read More

Entourage Health Corp. ( TSX-V:ENTG ) ( OTCQX:ETRGF ) ( FSE:4WE ) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products, announced today it has amended and upsized its existing credit facility (the “ Credit Facility ”) with an affiliate of the LiUNA Pension Fund of Central and Eastern Canada (“ LPF ”), adding an additional $8.9 million in non-dilutive funding availability... Read More

Entourage Health Corp. ( TSX-V:ENTG ) ( OTCQX:ETRGF ) ( FSE:4WE ) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products, is pleased to provide an update on the previously announced proposed amendments (the “ Proposed Amendments ” ) to the trust indenture dated as of September 25, 2019 between TSX Trust Company and the Company governing the Company’s 8.5% unsecured... Read More

Entourage Health Corp. ( TSX-V:ENTG ) ( OTCQX:ETRGF ) ( FSE:4WE ) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products, is pleased to announce that holders (the “ Debentureholders ”) of the Company’s 8.5% unsecured convertible debentures due September 25, 2022 (the “ Debentures ”), overwhelmingly approved the previously announced proposed amendments (the “ Proposed... Read More

Entourage Health Corp. ( TSX-V:ENTG ) ( OTCQX:ETRGF ) ( FSE:4WE ) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products, is pleased to announce that shareholders overwhelmingly approved all proposed resolutions at its annual general and special meeting of shareholders (“AGM”) held virtually in Toronto, Ontario on June 10, 2022. All director nominees, as listed in the... Read More

Entourage Health Corp. ( TSX-V:ENTG ) ( OTCQX:ETRGF ) ( FSE:4WE ) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products confirmed today it has signed an additional amendment to its senior secured credit facility entered into on March 29, 2019 (the “Credit Facility”). The latest amendments to the Credit Facility modify the terms under which Entourage secured up to $39... Read More

Gross revenue* of $17.4 million, up 28% sequentially and 37% year over year Total revenue of $15.8 million in Q1, 2022 represents a 17% sequential increase over Q4 2021 Gross Profit Before Fair Value Changes improved $5.5 million sequentially Adjusted EBITDA improved $1.0 million from Q4 2021, reflecting higher gross profit as Company realizes benefits from strategic transformation initiatives Upsized credit facility with... Read More

Entourage Health Corp. ( TSX-V:ENTG ) ( OTCQX:ETRGF ) ( FSE:4WE ) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products and The Boston Beer Company, Inc. (NYSE: SAM) , (“BBC”) maker of iconic, high-quality brands such as Samuel Adams, Truly Hard Seltzer and Twisted Tea, are... Read More

Initially available in Canada , TeaPot is the first beverage brand developed by BBCCC Inc, the cannabis subsidiary of Boston Beer. The Boston Beer Company, Inc. (NYSE: SAM), maker of iconic, high-quality brands such as Samuel Adams, Truly Hard Seltzer and Twisted Tea, today announced the launch of TeaPot, a new line of... Read More

Entourage Health Corp. ( TSX-V:ENTG ) ( OTCQX:ETRGF ) ( FSE:4WE ) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products announced today that it is scheduled to file its first quarter 2022 financial statements and management’s discussion and analysis after-market on Monday, May 30, 2022. Entourage will host a conference call the following day on Tuesday, May 31, 2022 at 10... Read More

Entourage Health Corp. (formerly WeedMD Inc.) ( TSX-V:ENTG ) ( OTCQX:ETRGF ) ( FSE:4WE ) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products, is pleased to announce that it has entered into voting support agreements with certain holders of the Company’s 8.5% unsecured convertible debentures due September 25, 2022 (the “ Debentures ”), including Hygrovest Limited, the... Read More

Entourage Health Corp. (formerly WeedMD Inc.) ( TSX-V:ENTG ) ( OTCQX:ETRGF ) ( FSE:4WE ) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products, announced today that George Scorsis, CEO and Executive Chair, and Vaani Maharaj, Chief Financial Officer, are scheduled to present at the Canaccord Genuity 6 th Annual Global Cannabis Virtual Conference on Thursday, May 11 th at 1... Read More

Net revenue increased to $42.2 million for the full year ended December 31, 2021 Preliminary unaudited Q1 2022 total revenue $17.4 million (1) representing 35% YOY growth Upsized credit facility with LiUNA Pension Fund further improves liquidity position Entourage Health Corp. (formerly WeedMD Inc.) ( TSX-V:ENTG ) ( OTCQX:ETRGF ) ( FSE:4WE ) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of... Read More

Entourage Health Corp. (formerly WeedMD Inc.) ( TSX-V:ENTG ) ( OTCQX:ETRGF ) ( FSE:4WE ) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products, announced today that the Ontario Securities Commission (the “OSC”) has issued a Cease Trade Order (the “CTO”) as a result of the Company not filing its financial statements for the year ended December 31, 2021 and the related... Read More

Entourage Health Corp. (formerly WeedMD Inc.) ( TSX-V:ENTG ) ( OTCQX:ETRGF ) ( FSE:4WE ) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products, announced today it has entered into an agreement with Fire & Flower Holdings Corp. (" Fire & Flower ") ( TSX: FAF; OTCQX: FFLWF ), a leading cannabis consumer retail and technology platform and its wholly owned delivery and... Read More

Company reaffirms previously announced full-year 2021 preliminary revenue with further improvements at $55.2 million (1) and preliminary gross margins of 7.0% (1) for the year Entourage Health Corp. (formerly WeedMD Inc.) ( TSX-V:ENTG ) ( OTCQX:ETRGF ) ( FSE:4WE ) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products, announced today it will defer its fourth quarter and... Read More

Entourage Health Corp. (formerly WeedMD Inc.) ( TSX-V:ENTG ) (OTCQX:ETRGF) (FSE:4WE) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products and brands, is pleased to announce it has amended and upsized its existing credit facility (the “ Credit Facility ”) with an affiliate of the LiUNA Pension Fund of Central and Eastern Canada (“ LPF ”), adding an additional $15 million... Read More

Company reaffirms preliminary fiscal year 2021 record revenue of $54.8 million (1) Results to be filed after-market May 2, 2022, with management hosting a call on following day Entourage Health Corp. (formerly WeedMD Inc.) ( TSX-V:ENTG ) ( OTCQX:ETRGF ) ( FSE:4WE ) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products announced today that it will file its fourth quarter... Read More

TORONTO, March 30, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) ( TSX-V:ENTG ) ( OTCQX:ETRGF ) ( FSE:4WE ) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products confirmed today it has signed an additional amendment (the “ Amendment ”) to its senior secured credit facility entered into on March 29, 2019 (the “ Credit Facility ”). The Amendment... Read More

Entourage Health Corp. (formerly WeedMD Inc.) ( TSX-V:ENTG ) ( OTCQX:ETRGF ) ( FSE:4WE ) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products and brands, announced today that its Royal City Cannabis Co. (“Royal City") brand recently launched ‘RC Joints for Justice’ , a... Read More

Ms. Maharaj to succeed Beth Carreon who is stepping down from CFO role effective May 4, 2022 Company also reaffirms preliminary fiscal year 2021 record revenue of $54.8 million (1) Management to host financial results conference call on April 26, 2022 at 10 a.m. Eastern time Entourage Health Corp. (formerly WeedMD Inc.) ( TSX-V:ENTG ) ( OTCQX:ETRGF ) ( FSE:4WE ) (“ Entourage ” or the “ Company ”), a Canadian producer and... Read More

Entourage Health Corp. (formerly WeedMD Inc.) ( TSX-V:ENTG ) ( OTCQX:ETRGF ) ( FSE:4WE ) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products and brands is pleased to unveil the refresh of its Color Cannabis (“Color”) adult-use brand with the launch of its new 2022 branding... Read More

FYE 2021 revenues up 54% over prior year due to record sales and expanded market share (1) Conference call to review financial results to be held on April 1, 2022 at 10 a.m. Eastern time Company also provides a corporate update to confirm George Scorsis as permanent CEO Entourage Health Corp. (formerly WeedMD Inc.) (... Read More

Entourage Health Corp. (formerly WeedMD Inc.) ( TSX-V:ENTG ) (OTCQX:ETRGF) (FSE:4WE) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products and brands issued an open letter to shareholders today to provide a recap of its corporate and operational achievements attained over the past year, and an overview of what is expected in 2022. The Company overview and Shareholder... Read More

Entourage Health Corp. (formerly WeedMD Inc.) ( TSX-V:ENTG ) (OTCQX:ETRGF) (FSE:4WE) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products and brands, announced today it has amended its existing credit facility (“ Credit Facility ”) with an affiliate of the LiUNA Pension Fund of Central and Eastern Canada (“ LPF ”) to add an additional $20 million in non-dilutive funding.... Read More

Entourage Health Corp. (formerly WeedMD Inc.) ( TSX-V:ENTG ) (OTCQX:ETRGF) (FSE:4WE) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products and brands, announced today it has upgraded its cultivation platform to include a unique Company-wide standardized system rooted in tissue culture propagation that is expected to drive commercial growth for premium products in 2022. In... Read More

Entourage Health Corp. (formerly WeedMD Inc.) ( TSX-V:ENTG ) (OTCQX:ETRGF) (FSE:4WE) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products and brands, is pleased to announce it has entered into a commercial arrangement with Olli Brands Inc. ("OBi”) to produce a suite of cannabis soft chews for sale under the Company’s Starseed Medicinal brand. Product availability is... Read More

Adult-Use net revenue for the quarter increased by 102% compared to last year Sales, general and administrative costs decreased by 16% compared to last year Strategic acquisition of craft cultivator CannTx will introduce new genetics, IP and cultivars Management to host conference call today at 10:00 a.m. Eastern Time Entourage Health Corp. (formerly WeedMD Inc.) ( TSX-V:ENTG ) (OTCQX:ETRGF) (FSE:4WE) (“ Entourage ” or the “... Read More

Entourage Health Corp. (formerly WeedMD Inc.) ( TSX-V:ENTG ) (OTCQX:ETRGF) (FSE:4WE) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products and brands, is pleased to announce it has strengthened its executive team with key strategic appointments in the areas of commercial sales, marketing, and business development as well as product development, cultivation and supply... Read More

Closing of deal merges craft brand Royal City Cannabis Co. into Entourage’s product portfolio Company enhances board with two new appointments from CannTx Life Sciences Entourage also completes amendments to its second secured $30 million credit facility Entourage Health Corp. (formerly WeedMD Inc.) ( TSX-V:ENTG ) (OTCQX:ETRGF) (FSE:4WE) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning... Read More

Fourth consecutive quarter of growth attributed to expanding market share and record sales Company also completes amendments to its $39 million senior secured credit facility Entourage Health Corp. (formerly WeedMD Inc.) ( TSX-V:ENTG ) (OTCQX:ETRGF) (FSE:4WE) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products and brands, is pleased to announce its preliminary unaudited... Read More

Entourage Health Corp. (formerly WeedMD Inc.) ( TSX-V:ENTG ) (OTCQX:ETRGF) (FSE:4WE) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products and brands, today announces that, as a result of a continuous disclosure review conducted by staff of the Ontario Securities Commission (“OSC”), the staff of the Corporate Finance Branch requested that the Company refile its... Read More

Entourage Health Corp. (formerly WeedMD Inc.) ( TSX-V:ENTG ) (OTCQX:ETRGF) (FSE:4WE) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products and brands, in collaboration with leading Canadian retailer Fire & Flower Inc. (“ Fire & Flower ”) ( TSX:FAF; OTCQX:FFLWF ), is pleased to announce the release of Fire & Flower’s “ Revity CBD™ Softgel” line. In addition to the CBD... Read More

Entourage Health Corp. (formerly WeedMD Inc.) ( TSX-V:ENTG ) (OTCQX: ETRGF), (formerly OTCQX: WDDMF) (FSE:4WE) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products and brands, announced that effective at market open on September 1, 2021, the OTCQX market ticker symbol for the Company’s common shares will change from “WDDMF” to “ETRGF” . The OTCQX symbol change is... Read More

Entourage holds exclusive rights to sell, market and distribute Boston Beer-branded and licensed non-alcoholic cannabis beverages produced by Althea’s subsidiary Peak Processing Company also enters into supply agreement with Peak to provide cannabinoid-rich input biomass to Peak to formulate and manufacture the cannabis beverage products in Canada Global cannabis beverage market is estimated to reach US$2.8 billion by 2025... Read More

In partnership with local producer ROSE LifeScience, following the launch of its Color Cannabis brand in Quebec, product portfolio expanded to include Saturday Cannabis Both product lines are now available for purchase via Société québécoise du cannabis (SQDC) Entourage Health Corp. (formerly WeedMD Inc.) ( TSX-V:ENTG ) (OTCQX:WDDMF) (FSE:4WE) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of... Read More

Continued record sales of higher-margin products in all channels drives 29% gross margin Fulfilled record purchase orders from every province, focusing on top-performing products resulting in a 159% increase in adult-use sales YOY and a 55% increase in Q2 market share Management to host conference call today at 10:00 a.m. Eastern Time Entourage Health Corp. (formerly WeedMD Inc.) ( TSX-V:ENTG ) (OTCQX:WDDMF) (FSE:4WE) (“... Read More

Entourage Health Corp. (formerly WeedMD Inc.) ( TSX-V:ENTG ) (OTCQX:WDDMF) (FSE:4WE) (“ Entourage ” or the “ Company ”), is pleased to announce preliminary unaudited revenues of $13.6 million (1) for the three months ended June 30, 2021, representing another sequential quarter of record sales growth across its adult-use and medical sales channels. The Company plans to file its second quarter 2021 financial statements and... Read More

Entourage Health Corp. (formerly WeedMD Inc.) ( TSX-V:ENTG ) (OTCQX:WDDMF) (FSE:4WE) (“ Entourage ” or the “ Company ”), is pleased to announce that as part of its corporate name change and rebrand from “WeedMD Inc.” to “Entourage Health Corp.”, the Company’s common shares (“ Common Shares ”) will continue to be publicly traded on the TSX Venture Exchange (the “ TSXV ”) under the new ticker symbol “ ENTG” , with a new CUSIP... Read More

On closing, merged company to combine innovative medical business, low-cost cultivation, specialized craft cannabis, micropropagation, and solventless extraction capabilities Top-selling, award-winning brands include Color Cannabis, Saturday Cannabis, Royal City Cannabis Co., Starseed Medicinal, and U.S. licensed-brand Mary’s Medicinals Strathroy, Aylmer and Guelph sites will create synergies and further cost efficiencies... Read More

Company reports results of Annual General & Special Meeting of Shareholders held on June 30, 2021 which includes overwhelming shareholder approval for corporate rebrand Company confirms the Management Cease Trade Order is lifted following the respective filing of its fiscal year-end 2020 financials and first quarter 2021... Read More

Total revenue (before excise duties) of $12.9 million in Q1 2021, represents over 7% favourability over the $12.0 million Q1 2021 guidance previously provided Net revenue of $10.3 million in Q1 2021, represents a 102% sequential increase over Q4 2020, reflecting record sales of higher-margin, direct-to-consumer, and direct-to-patient products Reports significant improvement in SG&A expenses, down 66% from previous quarter... Read More

WeedMD Inc. ( TSX-V:WMD ) (OTCQX:WDDMF) (FSE:4WE) (“ WeedMD ” or the “ Company ”), a federally licensed producer and distributor of medical-grade cannabis, is pleased to announce the expansion of its Color Cannabis brand into the Province of New Brunswick, following receipt of its first purchase order from Cannabis NB, the province’s legal recreational cannabis retailer. With the initial order for multi-pack, dried flower... Read More

Closes share-sale transaction with Final Bell Canada Inc. following Starseed Medicinal’s full production and product fulfillment move to Company’s consolidated London-area facilities Concludes site optimization strategy initiated in early 2021; Company intends to use net proceeds of sale primarily to pay down debt WeedMD Inc. ( TSX-V:WMD ) (OTCQX:WDDMF) (FSE:4WE) (“ WeedMD ” or the “ Company ”), a federally licensed producer... Read More

WeedMD Inc. ( TSX-V:WMD ) (OTCQX:WDDMF) (FSE:4WE) (“ WeedMD ” or the “ Company ”), a federally licensed producer and distributor of medical-grade cannabis, is providing a bi-weekly update on the status of the management cease trade order granted on May 3, 2021 (the " MCTO ") by its principal regulator, the Ontario Securities Commission, in accordance with the alternative information guidelines set out in National Policy... Read More

Strategic acquisition of innovative, specialized cannabis operator will fold in micro-propagation technology, a craft portfolio, and solventless extraction capabilities Complementary operations and combined brand portfolio meets emerging trends in consumer preference, alongside continued growth in new business verticals Guelph-based state-of-the-art facility will help create synergies and further cost efficiencies to bring... Read More

Net revenue increased 41% YOY to $29.4 million for the full year ended December 31, 2020 Kilograms harvested in 2020 grew 88% over prior year to 33,751 with more Grade A flower Weighted average cost per gram of $0.46 in 2020 decreased by 42% from $0.79 in 2019 partly due to cost efficiencies implemented Preliminary unaudited Q1 2021 gross revenue of $12 million (1) represents 40% growth in high-margin,... Read More

Company financials to be filed after market on May 28, 2021 and operational outlook to be provided during call, including first quarter 2021 record milestones achieved WeedMD Inc. ( TSX-V:WMD ) (OTCQX:WDDMF) (FSE:4WE) (“ WeedMD ” or the “ Company ”), a federally licensed producer and distributor of medical-grade cannabis, announced today that it will file its financial statements and management’s discussion and analysis for... Read More

WeedMD Inc. ( TSX-V:WMD ) (OTCQX:WDDMF) (FSE:4WE) (“ WeedMD ” or the “ Company ”), a federally licensed producer and distributor of medical-grade cannabis, is pleased to announce it has entered into an exclusive licensing and supply agreement (the “Agreement”) with Ontario craft cannabis producer CannTx Life Sciences Inc. (“CannTx”) to release celebrated cultivars “Rockstar Tuna” and “Royal Goddess” - re-labelled “Crown” -... Read More

WeedMD Inc. ( TSX-V:WMD ) ( OTCQX:WDDMF ) ( FSE:4WE ) (“ WeedMD ” or the “ Company ”), a federally licensed producer and distributor of medical-grade cannabis, is providing a bi-weekly update on the status of the management cease trade order granted on May 3, 2021 (the " MCTO ") by its principal regulator, the Ontario Securities Commission, in accordance with the alternative information guidelines set out in National Policy... Read More

WeedMD Inc. ( TSX-V:WMD ) ( OTCQX:WDDMF ) ( FSE:4WE ) (“ WeedMD ” or the “ Company ”), a federally licensed producer and distributor of medical-grade cannabis, is pleased to announce that George Scorsis, WeedMD’s CEO and Executive Chairman, and the Company’s newly appointed CFO Beth Carreon are scheduled to present at Canaccord Genuity’s 5th Annual Global Cannabis Conference on Tuesday May 11, 2021 at 3:30 p.m. ET. The... Read More

WeedMD Inc. ( TSX-V:WMD ) ( OTCQX:WDDMF ) ( FSE:4WE ) (“ WeedMD ” or the “ Company ”), a federally licensed producer and distributor of medical-grade cannabis confirmed today that further to its news release dated April 21, 2021, the Company's principal regulator, the Ontario Securities Commission (the " OSC ") granted a management cease trade order (the " MCTO ") on May 3, 2021, under National Policy 12-203 - Management... Read More

WeedMD Inc. ( TSX-V:WMD ) ( OTCQX:WDDMF ) ( FSE:4WE ) (“ WeedMD ” or the “ Company ”), a federally licensed producer and distributor of medical-grade cannabis announced today that the filing of its audited annual financial statements, management's discussion and analysis, and related CEO and CFO certifications for the financial year ended December 31, 2020 (the “ Required Filings ”), will be delayed beyond the filing... Read More

WeedMD Inc. ( TSX-V:WMD ) ( OTCQX:WDDMF ) ( FSE:4WE ) (“ WeedMD ” or the “ Company ”), a federally licensed producer and distributor of medical-grade cannabis, is pleased to announce that George Scorsis, WeedMD’s CEO and Executive Chair, is scheduled to participate in the following upcoming investor events. Planet MicroCap Showcase Virtual Panel - The Global Cannabis Industry in 2021 Date: URL: Tuesday, April 20, 2021 at... Read More

Formerly of Tilray Canada and Nestlé Canada, brings over 20 years of corporate finance, banking, M&A, and CPG experience Succeeds Lincoln Greenidge who is stepping down from CFO role effective April 30 th , 2021 WeedMD Inc. ( TSX-V:WMD ) (OTCQX:WDDMF) (FSE:4WE) (“ WeedMD ” or the “ Company ”), a federally licensed producer and distributor of medical-grade cannabis, is pleased to announce that Beth Carreon, a seasoned... Read More

WeedMD Inc. ( TSX-V:WMD ) (OTCQX:WDDMF) (FSE:4WE) (“ WeedMD ” or the “ Company ”), a federally licensed producer and distributor of medical-grade cannabis, announced today that it will file its financial statements and management’s discussion and analysis for the fourth quarter and fiscal year ended December 31, 2020, after market close on Thursday, April 29, 2021. The Company will host a conference call to discuss these... Read More

WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“ WeedMD ” or the “ Company ”), a federally licensed producer and distributor of medical-grade cannabis, is pleased to announce the Company has been added to the Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ) following HMMJ’s quarterly rebalancing, marking the Company’s return to this index of publicly traded North American companies with significant business activity... Read More

WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“ WeedMD ” or the “ Company ”), a federally licensed producer and distributor of medical-grade cannabis, is pleased to announce that the TSX Venture Exchange (the “ TSXV ”) has accepted for listing 19,046,875 common share purchase warrants of the Company (the “ Warrants ”) issued in connection with the Company’s previously announced bought deal short-form prospectus offering... Read More

WeedMD Inc. ( TSX-V:WMD ) (OTCQX:WDDMF) (FSE:4WE) (“ WeedMD ” or the “ Company ”), a federally licensed producer and distributor of medical-grade cannabis, is pleased to announce the debut of its strain-specific live resin product for release under its Color Cannabis adult-use brand, 510-thread vaporization carts. Products... Read More

WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“ WeedMD ” or the “ Company ”), a federally licensed producer and distributor of medical-grade cannabis, is pleased to announce it has closed its previously announced bought deal short-form prospectus offering of 35,937,500 units (“ Units ”) at a price of $0.48 per Unit for aggregate gross proceeds of $17,250,000, including full exercise of the over-allotment (the “ Offering... Read More

WeedMD Inc. (“ WeedMD ” or the “ Company ”) (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE), a federally-licensed producer and distributor of medical-grade cannabis, announced today that, further to its press release dated February 11, 2021 announcing a $17.5 million bought deal financing (the “ Offering ”), the Company has entered into an amended and restated underwriting agreement dated March 2, 2021, with Eight Capital and Canaccord... Read More

WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“ WeedMD ” or the “ Company ”), a federally licensed producer and distributor of medical-grade cannabis, announced today that it has amended and re-filed its unaudited reviewed interim financial statements for the three and nine months ended September 30, 2020 (the “ Amended Financial Statements ”), along with a corresponding restated management’s discussion and analysis... Read More

WeedMD Inc. ( TSX-V:WMD ) (OTCQX:WDDMF) (FSE:4WE) (“ WeedMD ” or the “ Company ”), a federally licensed producer and distributor of medical-grade cannabis, is pleased to announce it will commence selling Pedro’s Sweet Sativa, strain-specific PAX® ERA® products to its Starseed Medicinal clients starting March 6 th , 2021. The... Read More

Acclaimed Mary’s Medicinals Transdermal Compound, produced exclusively in Canada by WeedMD, with expected availability to Starseed Medicinal’s patients starting late February, 2021 Mary’s Medicinals expanded availability in Ontario expected in March 2021 Additional new product formats, including transdermal gels and patches,... Read More

WeedMD Inc. (“ WeedMD ” or the “ Company ”) (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce that it has entered into an amended letter of engagement with Eight Capital, under which Eight Capital has now agreed to purchase, as joint bookrunner and co-lead underwriter along with Canaccord Genuity Corp. (the “ Co-Lead Underwriters ”),... Read More

WeedMD Inc. ( TSX-V:WMD ) (OTCQX:WDDMF) (FSE:4WE) (“ WeedMD ” or the “ Company ”), a federally licensed producer and distributor of medical-grade cannabis is pleased to announce its terpene-infused, one-gram Saturday Cannabis (“Saturday”) vaporizer (“vapes”) was recently named “Top Selling Vape” for the month of January, 2021 at the Ontario Cannabis Store (“OCS”), Canada’s largest cannabis retail distributor. When compared... Read More

WeedMD Inc. ( TSX-V:WMD ) (OTCQX:WDDMF) (FSE:4WE) (“ WeedMD ” or the “ Company ”), a federally licensed producer and distributor of medical-grade cannabis confirmed its adult-use products sold under the Color Cannabis brand are now available for purchase in the province of Quebec. Following the completion of its first shipment to the Société québécoise du cannabis (“SQDC”), products are being distributed locally via... Read More

WeedMD Inc. ( TSX-V:WMD ) (OTCQX:WDDMF) (FSE:4WE) (“ WeedMD ” or the “ Company ”), a federally licensed producer and distributor of medical-grade cannabis, is pleased to announce that its subsidiary Starseed Medicinal Inc. (“ Starseed ”) has added eligible members of Labourers’ International Union of North America (“LiUNA”) Local 1258, headquartered in Manitoba, to its full-service medical cannabis program. Eligible members... Read More